Interpace Diagnostics (Exotistan) Price Prediction

Interpace Diagnostics Group Inc -- Exotistan Stock  

USD 0.53  0.06  10.17%

Macroaxis is not in business of monitoring Interpace Diagnostics headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with Interpace Diagnostics Group Inc brand which may create opportunities for some arbitrage if properly timed. With Interpace Diagnostics hype-based prediction module you can estimate the value of Interpace Diagnostics Group Inc from the prospective of Interpace Diagnostics response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Interpace Diagnostics over a specific investment horizon. Additionally take a look at Your Equity Center.
Investment Horizon     30 Days    Login   to change

Interpace Diagnostics Estimiated After-Hype Price Volatility

 Next price density 
 
Expected price to next headline
December 15, 2017
0.53
Current Value
Downside upside
0.00
After-hype Price
Target Price Odds
 Above  Below  
0.00
Upside
Upside upside
Interpace Diagnostics is Unknown risk asset. Analysis and calculation of next after-hype price of Interpace Diagnostics is based on 1 month time horizon.

Interpace Diagnostics Hype Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.00% 0.00% 0.00%  0.00% 0 Events / Month1 Events / MonthWithin a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.530.000.00%
0.00% 

Interpace Diagnostics Hype Timeline

Interpace Diagnostics Group Inc is at this time traded for 0.53 on Commodity Exchange of Exotistan. This company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Interpace Diagnostics Group Inc is projected not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is projected to be very small where as daily expected return is at this time at 0.0%. The volatility of relative hype elasticity to Interpace Diagnostics is about 0.0%%. The volatility of related hype on Interpace Diagnostics is about 0.0% with expected price after next announcement by competition of 0.53. About 61.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.66. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Interpace Diagnostics Group Inc has Price/Earnings (P/E) ratio of 748.0. This company recorded loss per share of 1.53. The firm had not issued any dividends in recent years. Given the investment horizon of 30 days, the next projected press release will be within a week.
Additionally take a look at Your Equity Center.

Interpace Diagnostics Related Hype Analysis